1. Sanofi (7 from 1,454 patents)

2. Aventis Pharma S.a. (4 from 377 patents)

3. Sanofi-aventis (2 from 389 patents)

4. Myokardia, Inc. (2 from 12 patents)

1. 12344607 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases

2. 11214541 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

3. 11149031 - Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof

4. 11034693 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases

5. 10570090 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

6. 9714221 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

7. 8993565 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

8. 8791255 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

9. 8507483 - 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation

10. 8461175 - 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof

11. 8163750 - Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90

12. 7674795 - Fluorene derivatives, composition containing said derivatives and the use thereof

13. 7435820 - [object Object]

14. 7119115 - Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology

15. 7109340 - Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use